# Filing Detail

Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-16-035178
Filing Date
2016-07-12
Accepted
2016-07-12 17:21:56
Documents
60
Period of Report
2016-02-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K/A | atrn20160630_8ka.htm | 8-K/A | 794025
2 | EXHIBIT 99.1 | ex99-1.htm | EX-99.1 | 588100
3 | EXHIBIT 99.2 | ex99-2.htm | EX-99.2 | 295280
10 |  | schulman.jpg | GRAPHIC | 376408
| Complete submission text file | 0001437749-16-035178.txt |  | 5641301

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | EXHIBIT 101.INS | atrn-20151231.xml | EX-101.INS | 746434
5 | EXHIBIT 101.SCH | atrn-20151231.xsd | EX-101.SCH | 49661
6 | EXHIBIT 101.CAL | atrn-20151231_cal.xml | EX-101.CAL | 32830
7 | EXHIBIT 101.DEF | atrn-20151231_def.xml | EX-101.DEF | 371010
8 | EXHIBIT 101.LAB | atrn-20151231_lab.xml | EX-101.LAB | 285001
9 | EXHIBIT 101.PRE | atrn-20151231_pre.xml | EX-101.PRE | 383819

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 000-51353 | Film No.: 161764538
SIC: 7389 Services-Business Services, NEC